BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM
The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most rapid benefit seen in ...
M&A News: Novartis Seals $3.1B Deal to Acquire Anthos
Novartis (NVS) has sealed a $3.1 billion deal to acquire clinical-stage biopharmaceutical company Anthos Therapeutics. The ...
Bayer backs broadened effort to shield popular weedkiller from claims it failed to warn of cancer
DES MOINES, Iowa (AP) — A renewed and expanded effort from chemical giant Bayer to shield itself from lawsuits that claim its ...